BioMark Diagnostics to attend MSACL 2026 conference

• BioMark Diagnostics will attend MSACL 2026 in Montreal on Oct. 4-9, 2026.
• Participation includes industry workshops with Sciex, Phytronix Technologies on clinical mass spectrometry workflows, assay applications.
• BIOHorizon 2026 participation set for Oct. 7-8, 2026, in Laval, Quebec.
• Chief Scientific Officer Jean-François Haince to join an Oct. 8 panel on translating biomarkers into clinical practice.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMark Diagnostics Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609210830NEWSFILECNPR____20260921_315081_1) on September 21, 2026, and is solely responsible for the information contained therein.